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Introduction
ER-associated degradation (ERAD) is an important compo-
nent of ER quality control whereby unwanted proteins that are 
misfolded, misassembled, or metabolically excessive are rec-
ognized and returned to the cytosol by a process called retro-
translocation or dislocation (Hampton, 2002; Jarosch et al., 
2002a; Tsai et al., 2002; Meusser et al., 2005). Once exposed to 
the cytosol, ERAD-targeted proteins are ubiquitinated and sub-
sequently degraded by the cytosolic proteasome. The fact that 
dysfunction in ERAD causes human diseases (McCracken and 
Brodsky, 2003) and many viral proteins hijack this pathway to 
evade detection by the immune system (Ploegh, 1998; Lybarger 
et al., 2005) highlights its importance.
Since ERAD was fi  rst appreciated over a decade ago, sev-
eral key players have been identifi  ed, particularly from a study 
of yeast (Meusser et al., 2005). However, our knowledge of how 
ERAD substrates are specifi  cally recognized and extracted from 
the ER lumen remains incomplete. Highly relevant to this ques-
tion, recent studies have demonstrated that distinct protein com-
plexes are formed at the ER membrane that are involved in the 
recognition, ubiquitination, and extraction of specifi  c substrate 
classes (Carvalho et al., 2006; Denic et al., 2006). Although 
only a few have been implicated in ERAD, ubiquitin (Ub) E3 
  ligases clearly play a central role in the organization of different 
ER membrane complexes involved in ERAD of distinct sub-
strate classes. For example, yeast E3 ligase Hrd1p/Der3p is a 
key component of a core membrane complex that processes 
substrates with lumenal lesions, the so-called ERAD-L pathway. 
This core complex includes membrane protein Hrd3p (Vashist 
and Ng, 2004; Carvalho et al., 2006; Denic et al., 2006) that re-
cruits lumenal folding sensor Yos9p (Bhamidipati et al., 2005; 
Kim et al., 2005) as well as the membrane protein Ubx2p 
that recruits the cytosolic cdc48 ATPase complex (Schuberth 
and Buchberger, 2005). On the other hand, Doa10p, another 
well-characterized yeast E3 ligase implicated in ERAD, is a 
key and central component of a core membrane complex that 
processes ERAD substrates with lesions in their cytoplasmic 
  domains, a so-called ERAD-C pathway (Vashist and Ng, 2004; 
Carvalho et al., 2006). This Doa10p complex includes Ubc7 
and its membrane anchor Cue1 as well as cdc48 and its co-
factors. However, the specifi  c factors that are capable of recog-
nizing the defect in the cytoplasmic tail of a substrate have not 
been defi  ned. Nevertheless, substrate ubiquitination as specifi  -
cally rendered by the E3 ligase is required for both pathways to 
completely remove the ERAD target from the ER by the cdc48 
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T
he mechanism by which substrates for endoplasmic 
reticulum–associated degradation are retrotrans-
located to the cytosol remains largely unknown, al-
though ubiquitination is known to play a key role. The 
mouse γ-herpesvirus protein mK3 is a viral RING-CH–type 
E3 ligase that speciﬁ  cally targets nascent major histocom-
patibility complex I heavy chain (HC) for degradation, 
thus blocking the immune detection of virus-infected cells. 
To address the question of how HC is retrotranslocated 
and what role mK3 ligase plays in this action, we investi-
gated ubiquitin conjugation sites on HC using mutagenesis 
and biochemistry approaches. In total, our data demon-
strate that mK3-mediated ubiquitination can occur via 
serine, threonine, or lysine residues on the HC tail, each of 
which is sufﬁ  cient to induce the rapid degradation of HC. 
Given that mK3 has numerous cellular and viral homo-
logues, it will be of considerable interest to determine the 
pervasiveness of this novel mechanism of ubiquitination.
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ATPase complex (Biederer et al., 1997; Jarosch et al., 2002b; 
Flierman et al., 2003). Within this basic framework of how dif-
ferent substrates are targeted for ERAD, several critical ques-
tions remain. For example, in the context of each pathway, 
(1) how do E3 ligases impose substrate specifi  city, and (2) at 
which step of ERAD does substrate ubiquitination occur?
Whether different pathways defi  ned in yeast such as the 
ERAD-L and ERAD-C pathways are conserved in mammals is 
not well established. However, the fact that most components of 
ERAD defi  ned in yeast have functional homologues in mammals 
suggests evolutionary conservation. In agreement with this hy-
pothesis, ER membrane core complexes, including E3 ligases that 
link ERAD substrates to ubiquitination and extraction machinery, 
have been defi  ned in human cell studies (Lilley and Ploegh, 2005; 
Ye et al., 2005). However, the mammalian ERAD mechanism is 
clearly more complex. For example, three Der1p homologues 
have been defi  ned in mammals, which are designated as Derlin1, 
2, and 3. Derlin1 but not Derlin2 plays a central role in ERAD of 
major histocompatibility complex (MHC) class I heavy chain 
(HC) by human cytomegalovirus protein US11 (Lilley and Ploegh, 
2004; Ye et al., 2004). In contrast, both Derlin2 and 3 are associ-
ated with EDEM (ER degradation–enhancing α-mannosidase–
like protein) and p97 (cdc48 in yeast) and are functionally required 
for ERAD of NHK (null Hong Kong), a misfolded glycosylated 
luminal protein in the ER (Oda et al., 2006).
Higher eukaryotic cells presumably have many additional 
E3 ligases participating in ERAD compared with yeast. For ex-
ample, mammals have a homologue of the yeast RING-H2–type 
E3 ligase Hrd1p called HRD-1 (Kaneko et al., 2002; Nadav 
et al., 2003; Kikkert et al., 2004). However, mammals have an 
additional RING-H2–type E3 ligase not found in yeast called 
gp78 (Fang et al., 2001; Liang et al., 2003). Interestingly, both 
HRD1 and gp78 are found in the same multiprotein ER mem-
brane complex containing Derlin1 and p97 (Ye et al., 2005). 
Whether they are responsible for distinct subsets of ERAD sub-
strates or share the same substrates is not yet clear. Furthermore, 
multiple lines of evidence indicate that US2 and US11, two hu-
man cytomegalovirus-encoded immune evasion proteins, use 
distinct ERAD pathways to target HC for ERAD (Lilley and 
Ploegh, 2005; Hassink et al., 2006). However, neither HRD1 
nor gp78 is required for US2- or US11-induced ERAD, sug-
gesting that they may recruit novel E3s (Lilley and Ploegh, 
2005; Ye et al., 2005). Collectively, these fi  ndings clearly sug-
gest that mammals have evolved very specifi  c and highly regu-
lated ERAD pathways servicing distinct substrates.
Immune evasion protein mK3 is a viral E3 ligase encoded 
by mouse γ-herpesvirus 68 (Virgin et al., 1997). It was previously 
shown that mK3 specifi   cally targets nascent HC for rapid 
degradation in an ubiquitination-proteasome–dependent manner 
(Boname and Stevenson, 2001; Yu et al., 2002). The RING-CH 
domain presumably conferring mK3 ligase activity is highly 
conserved among members of the K3 family, which includes a 
group of viral proteins encoded by herpesviruses and poxviruses 
(Coscoy and Ganem, 2003; Lehner et al., 2005). Cellular K3 
  homologues have also been detected, although their physiological 
function remains to be defi  ned (Lehner et al., 2005). Interestingly, 
one of the cellular K3 homologues in human named MARCH VI 
(TEB4) has been recently identifi  ed as a homologue of Doa10p 
based on its ER localization and conserved cytosolic RING-CH 
domain with E3 ligase activity (Bartee et al., 2004; Hassink et al., 
2005; Kreft et al., 2006). However, whether MARCH VI is a 
functional homologue of Doa10p remains to be determined.
We previously demonstrated that the specifi  c recognition 
of HC by mK3 required its association with transporter associ-
ated with antigen processing (TAP; Yu et al., 2002; Lybarger 
et al., 2003), a transporter of peptides into the ER lumen (Pamer 
and Cresswell, 1998). mK3 is also physically associated with 
p97 and Derlin1, suggesting that mK3 exploits a physiological 
Figure 1.  The K residues of MHC class I HC are dispensable 
for mK3-mediated HC down-regulation. (A) The structure of 
the ectodomain of L
d was generated using published coordi-
nates of the L
d–p29 complex (Protein Data Bank 1LD9). There 
are a total of 12 K residues on the L
d molecule: the three on 
the cytoplasmic tail are K308, K316, and K337, and the nine 
on the ectodomain are shown in the structure. Of the nine, six 
conserved Ks are underlined, and the other three (K31, K173, 
and K196) are unique to L
d. (B) WT3 cells expressing wild-
type (wt) or K-less L
d were cotransduced with one of the follow-
ing constructs: pMIG only (vector), pMIG.mK3 (mK3), or 
pMIG.mK3 C48G, C51G (an mK3 RING-CH domain mutant 
named mK3 RING mut). Flow cytometric analysis of surface L
d 
expression (detected by 30-5-7 staining) versus GFP ﬂ  uores-
cence is shown. The number in each plot represents the ratio 
of L
d staining intensities between GFP
+ and GFP
− popula-
tions. (C) Cells used in B were enriched by sorting the GFP
+ 
fraction of the transduced cell line. These enriched cells were 
incubated for 24 h with 125 U/ml IFN-γ, pulse labeled with 
[
35S]Cys/Met, and chased for the indicated times with unla-
beled Cys/Met. L
d precipitates were resolved by SDS-PAGE 
and visualized by autoradiography. L
d and β2m bands are 
indicated (left). In the right panel, relative band intensities 
from the gels are plotted as a percentage of the intensity at 
time zero for each cell line.MK3 UBIQUITINATES NONLYSINE RESIDUES ON MHC-I TAIL • WANG ET AL. 615
ERAD pathway (Wang et al., 2006). Curiously, polyubiqui-
tinated HCs detected in the presence of mK3 were membrane 
bound, but lysine (K) residues in the HC tail were not required for 
mK3-induced degradation (Wang et al., 2005). Based on these 
observations and similar fi  ndings with other ERAD substrates, 
a partial dislocation model was proposed whereby ectodomain 
residues of the substrate are ubiquitinated after exposure to the 
cytosol (Meusser and Sommer, 2004; Hassink et al., 2006). 
 Recent  fi  ndings also mandated that N-terminal or non-K forms 
of ubiquitination be considered (for review see Ciechanover and 
Ben Saadon, 2004; Cadwell and Coscoy, 2005).
In this study, we present unequivocal evidence that the cyto-
plasmic tail of HC is directly ubiquitinated in the presence of 
mK3 and that S or T residues are suffi  cient to induce the ubiqui-
tination and rapid degradation of HC. These fi  ndings implicate 
a novel chemical mechanism of substrate ubiquitination via 
ester linkages. Mechanistically, our fi  ndings demonstrate that 
mK3-induced ubiquitination does not require partial dislocation 
of the N terminus of HC. Alternatively, our data support a model 
whereby mK3 substrates are dislocated via their C terminus 
after tail ubiquitination. These combined observations explain 
how the mK3 ligase can function as a central component of a 
core ER membrane complex constructed for the specifi  c targeting 
of HC for ERAD.
Results
mK3-mediated MHC class I ubiquitination 
and rapid degradation are independent 
of lumenal Ks
How ERAD substrates, especially ER membrane proteins, are 
extracted from the ER membrane remains elusive, although it 
has been known for a long time that ubiquitination of substrates 
is pivotal. We previously demonstrated that mK3 induces poly-
ubiquitination and rapid degradation of HC with K-less tails 
(Wang et al., 2005). Given the fact that all of the functional 
ubiquitination components or domains, including mK3, are lo-
cated outside of the ER, this fi  nding and similar fi  ndings with 
other ERAD substrates (Shamu et al., 1999; Yu and Kopito, 
1999; Meusser and Sommer, 2004) raised the possibility that 
K residues in the HC ectodomain were being ubiquitinated. The 
presumption is that ERAD substrates can be partially dislocated 
to the cytosol before ubiquitination. If this is the case for mK3-
induced ERAD of HC, identifying which K residues in the 
  ectodomain of HC are ubiquitinated would lend strong support 
to a partial dislocation model.
To determine whether and which K residues on the HC are 
required for ubiquitination, we took a mutagenesis approach 
 using  L
d as a prototypic MHC class I HC. As shown in Fig. 1 A, 
a total of nine Ks were replaced by arginines (Rs) singly or in 
groups based on HC domain structure. Because our previous 
study had shown that tail Ks were dispensable for mK3-mediated 
Ub conjugation and rapid degradation of HC (Wang et al., 
2005), all ectodomain K mutations were introduced on a K-less 
tail template. Surface expression and TAP association were 
confi  rmed for all mutants to rule out gross misfolding. We next 
coexpressed each L
d K mutant with mK3 to test its capacity to 
be mK3 regulated. The results were unequivocal and un  expected. 
None of the individual mutations, groups of mutations, or even 
totally K-less L
d were found to have a substantial impact on 
mK3-mediated HC down-regulation (unpublished data). For 
example, in the presence of mK3, surface K-less L
d was re-
duced >25-fold (Fig. 1 B) and rapidly degraded with kinetics 
similar to wild-type (wt) L
d (Fig. 1 C). Thus, mK3 down-regulation 
of HC is clearly not compromised by the absence of K residues 
in the substrate.
Down-regulation of K-less HC requires 
the Ub–proteasome pathway
To establish physiological relevance, we next tested whether the 
degradation of K-less HC was also dependent on Ub conjugation 
and proteasome activity. As expected, the surface down-regulation 
Figure 2.  Down-regulation of completely K-less L
d is ubiquitination-
  proteasome dependent. (A) L
d HCs were immunoprecipitated with mAbs 
(30-5-7 and 64-3-7) from NP-40 lysates of the cell lines used in Fig. 1 B. 
Precipitates with or without endo H treatment were separated by SDS-
PAGE and blotted for Ub and L
d HC. In the right panel, the β-actin blot was 
included as a loading control. (B) After incubation for 2 h with 5 μM/ml of 
the proteasome inhibitor (PI) clasto-lactacystin β-lactone, cells expressing 
wt L
d or K-less L
d (±mK3) were harvested and NP-40 lysed. L
d HCs were 
precipitated, treated, or mock treated with endo H and were blotted with 
the indicated antibodies. (C) Lysates from B were blotted for mK3 (rabbit 
anti-mK3). The β-actin blot was included to control for equal loading.JCB • VOLUME 177 • NUMBER 4 • 2007  616
and the polyubiquitination of K-less L
d were both detected only 
in the presence of wt mK3 but not the RING mutant (C48G, 
C51G mutations in its RING-CH domain; Figs. 1 B and 2 A, 
respectively). More importantly, the appearance of polyubiqui-
tinated forms of K-less L
d in the presence of mK3 correlated 
with a lower steady-state level of unconjugated molecules. In 
contrast, in cells expressing the mK3 RING mutant, K-less L
d 
molecules were not Ub conjugated and were dramatically stabi-
lized (Fig. 2 A). Thus, similar to wt L
d, down-regulation of 
K-less L
d was dependent on the polyubiquitination of HC facili-
tated by mK3. Moreover, compared with wt L
d, K-less L
d showed 
a strikingly similar pattern of ubiquitination (Fig. 2 B, lanes 9–12 
vs. lanes 3–6). When treated with proteasome inhibitor, the 
polyubiquitinated conjugates of K-less L
d accumulated (Fig. 
2 B, top; lanes 10 and 12 vs. lanes 9 and 11, respectively), and 
 unconjugated  K-less  L
d was stabilized in cells expressing mK3 
(Fig. 2 B, bottom; lanes 10 and 12 vs. lanes 9 and 11, respectively). 
These combined fi  ndings demonstrate that degradation of K-less 
HC, like wt HC, is ubiquitination and proteasome dependent. 
The implication of the aforementioned fi  ndings is that there 
must be sites other than the ε-NH2 group of K on HC for mK3-
induced ubiquitination. As recently reviewed, a few recent stud-
ies have suggested that the fi  rst Ub moiety can be fused linearly 
to the α-NH2 group on the N-terminal residue of select substrates 
(for review see Ciechanover and Ben Saadon, 2004).
Fusion of a Ub moiety on the N terminus 
of HC does not induce ERAD of HC in the 
absence of mK3
To test the likelihood and consequences of the N-terminal ubiq-
uitination of HC by mK3, four different Ub/HC fusion proteins 
were made. More specifi  cally, fusion proteins with either a wt 
or K-less Ub moiety were attached to the N terminus of either 
wt or K-less L
d. For these fusion proteins, the G76 residue of 
Ub was replaced with valine to avoid detection by deubiqui-
tinating enzymes (Johnson et al., 1995; Baker, 1996; Dantuma 
et al., 2000). When expressed in WT3 cells, these fusion pro-
teins (1) were glycosylated with N-linked endoglycosidase H 
(endo H)–sensitive glycans, (2) assembled normally with β2m, 
and (3) attained native class I folding based on their detection 
with conformation-dependent mAb. Thus, these fusion proteins 
clearly have the appropriate topology in the ER. Our rationale 
for this approach was the prediction that adding a K-less Ub 
to the N terminus might be unfavorable for polyubiquitination 
and ERAD based on the fi  ndings that the addition of large 
N-terminal tags (e.g., 6× myc or GFP) to the substrate prevented 
the degradation of proteins known to be capable of N-terminal 
ubiquitination (Ciechanover, 2005). Alternatively, fusion of a 
wt Ub moiety on HC might facilitate ERAD because it should 
be readily polyubiquitinated if or when it gains access to the 
  cytosol. The rationale of making fusion proteins with K-less L
d 
as well as wt L
d was to determine whether the removal of Ks 
might promote N-terminal ubiquitination.
To test these possible scenarios, a pulse-chase experiment 
was conducted with cells expressing each of the four different 
fusion proteins to compare their relative stability in the presence 
or absence of mK3. As shown in Fig. 3 A, in the absence of 
mK3, both wt and K-less Ub/L
d fusion proteins were quite sta-
ble throughout the chase time (lanes 1–4; and not depicted). 
This demonstrates that N-terminal ubiquitination of HC alone is 
not suffi  cient to trigger a rapid degradation. A likely explanation 
is that the N terminus of HC does not gain access to the cytosol 
Figure 3.  Ubiquitination and degradation of Ub/L
d fusion 
proteins in the presence of mK3. (A) After incubation for 24 h 
with 125 U/ml IFN-γ, WT3 cells expressing Ub wt/L
d K-less 
or Ub K-less/L
d K-less (±mK3) were pulse labeled with 
[
35S]Cys/Met for 15 min and chased for the indicated times. 
Ub/L
d fusion molecules were precipitated by anti-L
d mAbs. 
Precipitates then were resolved by SDS-PAGE and visualized 
by autoradiography (left). Relative band intensities from these 
gels were plotted as a percentage of the intensity at time zero 
for each line (right). (B) Cells used in A were Dounce homoge-
nized. The homogenate was then subjected to serial centrifu-
gations from 1,000 to 100,000 g. After digestion (or mock 
digestion) with 10 μg/ml proteinase K for 20 min on ice, 
Ub/L
d molecules were precipitated from NP-40 lysates of 
100,000 g pellet (P) or supernatant (S) and analyzed by 
  immunoblotting using anti-Ub mAb or rabbit anti-L
d cyto  plasmic 
tail (cyt tail) antibodies. Polyubiquitinated forms are indicated 
by asterisks.MK3 UBIQUITINATES NONLYSINE RESIDUES ON MHC-I TAIL • WANG ET AL. 617
in the absence of mK3. However, in the presence of mK3, both 
wt Ub and K-less Ub/L
d fusion proteins were rapidly degraded 
(Fig. 3 A, lanes 5–8; and not depicted). More strikingly, all 
of these fusion proteins displayed similar ubiquitination pat-
terns in cells with mK3 (unpublished data). These results argue 
against an N-terminal Ub conjugation. However, how these 
  fusion proteins were polyubiquitinated, especially the one 
with K-less Ub fused to K-less L
d, remained unknown.
To solve this puzzle, a proteinase K assay was adopted to 
determine the site of the polyubiquitinated portion of com-
pletely K-less Ub/L
d fusion proteins. It was formally possible 
that the N terminus of K-less Ub/K-less L
d was polyubiqui-
tinated after partial dislocation. If this was the case, the cytosolic-
exposed N termini of fusion proteins as well as their poly-  Ub 
forms would be sensitive to proteinase K digestion. To test 
this possibility, the ER fraction from cells expressing K-less 
Ub/K-less L
d was isolated by ultracentrifugation. The isolated 
ER fraction was then subjected to proteinase K digestion fol-
lowed by immunoprecipitation of HC and blotting for Ub. As 
expected, Ub/L
d fusion HCs were observed only in the pellet 
fraction but not in the supernatant (Fig. 3 B), indicating that the 
Ub/L
d fusion protein is ER membrane bound, thus validating 
the ER isolation. Again, the poly-Ub bands were observed asso-
ciated with HC precipitates in mK3-expressing cells but not in 
the cells without mK3 (Fig. 3 B, top; lanes 9 and 10 vs. lanes 3 
and 4; poly-Ub forms are demarcated with asterisks). Also as 
expected, the polyubiquitinated and unconjugated HC bands 
were comparably sensitive to endo H, demonstrating that mK3 
was modifying ER membrane–bound newly synthesized fusion 
proteins (Fig. 3 B, lane 10 vs. lane 9).
Upon digestion of the membrane fraction by proteinase K, 
domains exposed to the cytosol should be cleaved. Indeed, when 
treated with proteinase K, the K-less Ub/K-less L
d fusion 
protein was slightly reduced in size, resulting in a faster gel mi-
gration (Fig. 3 B, Ub blot; lanes 5 and 6 vs. lanes 3 and 4 and 
lanes 11 and 12 vs. lanes 9 and 10, respectively). Furthermore, 
the proteinase K–treated fusion protein was only detected by an 
antibody against Ub but not by an antibody to the L
d cytoplasmic 
tail (Fig. 3 B, lanes 11 and 12). Thus, proteinase K cleaved the 
HC tail of the fusion protein, demonstrating that it was in the 
cytosol, whereas the N-terminal Ub moiety was undisturbed, 
suggesting that it resided in the lumen. More strikingly, the 
poly-Ub conjugation bands also disappeared when the tail was 
cleaved by proteinase K (Fig. 3 B, Ub blot; lanes 11 and 12 vs. 
lanes 9 and 10), suggesting that the cytoplasmic tail of Ub/L
d 
fusion protein is the site of poly-Ub chain formation induced 
by mK3.
The cytoplasmic tail of HC is the site 
of Ub conjugation mediated by mK3
To rule out the possibility that the fusion proteins used an alter-
native pathway, a similar experiment was conducted with cells 
expressing either wt or K-less L
d. Again, we observed that poly-
Ub forms of both wt and K-less L
d are ER membrane associated 
and disappear when the HC tail is removed (Fig. 4 A and not 
depicted), suggesting that for both Ub/L
d fusion protein and wt L
d, 
the cytoplasmic tail is the site of Ub conjugation. Although we 
considered it unlikely, the possibility remained that proteinase K 
was removing poly-Ub from the N terminus of L
d or Ub/L
d 
that occurred after partial dislocation to the cytosol. If this was 
the case, the cytoplasmic tail would not have to be the site of 
ubiquitination. To further demonstrate that the tail is the site of 
ubiquitination, a thrombin (TMB) cleavage site, LVPRGG, was 
engineered into the tail of L
d right after the basic cluster 
KRRRNT proximal to the transmembrane domain. The K resi-
due in this basic cluster was replaced by R. This molecule 
(L
d TMB) was normally glycosylated, β2m assembled, and 
folded when expressed in WT3 cells (unpublished data). In the 
presence of mK3, L
d TMB molecules were polyubiquitinated in 
a pattern similar to L
d (Fig. 4 B).
Lysates from cells expressing mK3 and wt L
d or L
d TMB 
were immunoprecipitated with antibodies specifi  c for the lumenal 
domain of L
d followed by TMB treatment. As expected, in the 
Figure 4. Polyubiquitinated  L
d HCs were no longer detectable when the 
cytoplasmic tail of HC was removed. (A) Similar procedures as described 
in Fig. 3 B were used for analysis of the cells expressing wt L
d (±mK3). Pre-
cipitates of L
d HCs were immunoblotted by anti-Ub mAb, anti-L
d lumenal 
mAbs (64-3-7), and anti-L
d cytoplasmic tail antibodies. Polyubiquitinated 
forms are indicated by asterisks. (B) L
d HCs were precipitated from NP-40 
lysates of the cells coexpressing mK3 and wt L
d or mK3 and L
d TMB (wt L
d 
with a K308R mutation and an engineered TMB cleavage site in its cyto-
plasmic tail; the tail sequence of this molecule is V  M  R  R  R  R  N  T  L  V  P  R  G  G  K  G-
G  D  Y  A  L  A  P  G  S  Q  S  S  E  M  S  L  R  D  C  K  A  , with the TMB cleavage site in bold). After 
incubation with TMB at room temperature for 3 h and then at 4°C over-
night, the precipitates were analyzed by immunoblotting using the indi-
cated antibodies.JCB • VOLUME 177 • NUMBER 4 • 2007  618
presence of TMB, only the tails of L
d TMB molecules and not 
wt L
d were cleaved, as demonstrated by their faster migration 
and by blotting with the tail-specifi  c antibody (Fig. 4 B, lanes 7 
and 8 vs. lanes 5 and 6). In comparison, wt L
d molecules were 
resistant to the TMB treatment (Fig. 4 B, lanes 3 and 4 vs. lanes 
1 and 2), indicating a specifi  c and successful TMB cleavage. 
More importantly, along with the cleavage of the tail of L
d, the 
polyubiquitinated forms of L
d TMB also disappeared (Fig. 4 B, 
Ub blot; lanes 7 and 8). Because TMB treatment should not 
  affect N-terminal polyubiquitination, these experiments along 
with the proteinase K experiments clearly defi  ned the HC tail 
and not the N terminus as the site of ubiquitination. Importantly, 
the same observations were obtained with proteinase K–treated 
K-less L
d or tail K-less L
d TMB (unpublished data). Thus, the 
clear implication was that ubiquitination of HC by mK3 likely 
occurs on non-K residues. Notably, it was recently reported that 
the ubiquitination of class I HC induced by MIR1 (also called 
kK3), an E3 ligase of Kaposi’s sarcoma-associated herpesvirus 
(KSHV), requires a C residue in the cytoplasmic tail of MHC-I 
molecules (Cadwell and Coscoy, 2005).
Cysteine-conjugated ubiquitination 
is not required for mK3-mediated 
down-regulation of HC
To test whether the mK3-induced ubiquitination of HC, like the 
MIR1-induced ubiquitination of HC, is dependent on a C resi-
due in the tail of HC, a new L
d mutant was made. The L
d tail has 
a single C at position 336 that is conserved among most mouse 
HCs. Thus, to test the importance of the tail C residue, a C336S 
point mutation was introduced onto a tail K-less L
d template 
(Fig. 5 A). WT3 cells were cotransduced with this construct, 
termed L
d tail KC-less, and mK3. In the presence of mK3, this 
KC-less mutant displayed prominent polyubiquitination (Fig. 
5 B) and rapid degradation (Fig. 5 C) similar to wt L
d. Thus, 
  unlike MIR1, a C residue in the HC tail is not required for HC to 
be a substrate for mK3-induced ubiquitination and degradation. 
To extend this fi  nding and rule out the possibility that C resi-
dues in the HC ectodomain are required for mK3 ubiquitina-
tion, L
d HC molecules were immunoprecipitated and eluted in 
the presence of the thioester-reducing agent 2-mercaptoethanol 
(2ME; Fig. 5 D). It should be noted that this is the same treat-
ment used to disrupt the aforementioned ubiquitination of HC 
by KSHV protein MIR1 (Cadwell and Coscoy, 2005). Dissocia-
tion of the Ig to heavy and light chains (Fig. 5 D, lanes 1–4 vs. 
lanes 5–8; indicated by arrows) was an internal control demon-
strating the effectiveness of the reduction. However, comparison 
of the sample with and without 2ME treatment showed no re-
duction in the levels of polyubiquitination of wt or K-less L
d. 
These combined mutagenesis and chemical fi  ndings demon-
strate that mK3-induced polyubiquitination does not require 
C residues in its HC substrate.
Direct ubiquitination of an S or T 
residue on the HC tail is sufﬁ  cient 
to induce rapid degradation
Although it was predicted that they would have insuffi  cient sta-
bility, T and S residues have hydroxyl groups that could poten-
tially form ester bonds with Ub (Yu and Kopito, 1999; for 
review see Ciechanover and Ben Saadon, 2004). To test this 
hypothesis, we made a construct without any of the four poten-
tial residues in the tail for Ub conjugation. In total, three Ks, 
4 Ss, 1 T, and 1 C in the tail of L
d were mutated (sequence shown in 
Fig. 6 A), but the ectodomain and transmembrane portion of wt L
d 
were unchanged. The resulting construct, termed KCST-less 
Figure 5.  The C residue in the tail of L
d HC is not required for 
its ubiquitination and rapid degradation mediated by mK3. 
(A) Sequence alignment of the cytoplasmic tails of wt L
d and a 
tail KC-less mutant is shown with wt residues in bold and sub-
stituted residues in red. (B) Polyubiquitination of L
d HCs in the 
cells expressing wt L
d or tail KC-less L
d (±mK3) was examined 
by immunoprecipitation of L
d HCs from NP-40 lysates (±endo 
H treatment) and immunoblotting for Ub. (C) After incubation 
for 24 h with 125 U/ml IFN-γ, cells used in B were pulse labeled 
with [
35S]Cys/Met for 15 min and chased for the indicated 
times. L
d HCs were precipitated, resolved, and visualized as 
described in Fig. 1 C. Relative band intensities from the gels 
are plotted as a percentage of the intensity at time zero for 
each line and are shown beside the gel photos. (D) After incu-
bation with 60 μM MG132 for 2 h, wt L
d HCs or K-less L
d HCs 
were precipitated by anti-L
d mAbs and eluted in the presence 
or absence of 5% 2ME at pH 8.0. Precipitates then were ana-
lyzed by immunoblotting for Ub and L
d HC. Ig bands are indi-
cated by arrows; nonreduced or reduced (non-rd or rd) L
d HC 
bands and poly-Ub forms (Ubn) are also indicated.MK3 UBIQUITINATES NONLYSINE RESIDUES ON MHC-I TAIL • WANG ET AL. 619
L
d tail, was stably expressed in WT3 cells with and without 
mK3. The ubiquitination status as well as the steady-state level 
of this L
d mutant was examined. As shown in Fig. 6 B, poly-
ubiquitination of this KCST-less mutant was undetectable com-
pared with wt L
d (left; third and fourth lanes vs. fi  rst and second 
lanes), although both cell lines expressed similar amounts of 
mK3 (Fig. 6 B, right). Concomitant with substantially dimin-
ished polyubiquitination, the KCST-less mutant was consider-
ably more stable than wt L
d (Fig. 6 D). To rule out the possibility 
that resistance of this mutant to mK3 is the result of impaired 
mK3 interaction, we demonstrated that the KCST-less mutant 
coimmunoprecipitated with mK3 similar to wt L
d (unpublished 
data). Thus, the removal of Ks and all residues with the poten-
tial to form ester bonds from the HC tail did not affect its ability 
to associate with mK3, only its ability to be ubiquitinated by 
mK3. The fact that the polyubiquitined forms disappeared 
when KCST residues were removed from only the tail of L
d 
and not the rest of the protein corroborated the conclusion that 
the tail is the site of ubiquitination. Furthermore, the fact that 
the KC-less tail mutant was ubiquitinated by mK3 but the tail 
KCST-less was not clearly implicated S and/or T residues in 
mK3 function.
We next compared the ability of individual residues to 
  restore mK3-induced ubiquitination in the KCST-less tail. For 
these comparisons, one K (K337), one C (C336), one S (S329), 
or one T (T313) was added back to the KCST-less tail mutant of 
L
d (Fig. 6 A). These locations were selected because they are 
highly conserved among HC alleles. Because the T313 residue 
is membrane proximal, whereas the other potential Ub sites 
were clustered toward the C terminus of the tail, we also con-
structed a T337 mutant. Strikingly, a single S or T residue near 
the C terminus of the HC tail resulted in substantial polyubiqui-
tination similar to the polyubiquitination of a single K in the 
presence of mK3 (Fig. 6, B and C; left). In contrast, the single 
C residue near the C terminus or the membrane-proximal T resi-
due only showed very weak or undetectable ubiquitination. 
These fi  ndings suggested that hydoxylated amino acids (either 
S or T) can be sites of Ub conjugation but that location toward 
the C terminus of the tail is critical (Fig. 6, B and C; left). 
  Importantly, similar levels of mK3 were expressed in these 
cells (Fig. 6, B and C; right). Consistent with Ub conjugation, 
the S329, T337, and K337 mutants were more rapidly degraded 
in mK3-expressing cells compared with the KCST-less tail 
mutant (Fig. 6 D).
The fact that the 1S or 1T (337) tail was polyubiquitinated 
and degraded in the absence of K residues largely ruled out the 
likelihood that S or T residues are required for other modifi  ca-
tions, such as phosphorylation (Meusser and Sommer, 2004). 
However, the possibility remained that the observed ubiquitina-
tion of a K-less ERAD substrate might be the result of the ubiq-
uitination of adaptor proteins (Yu and Kopito, 1999; Hassink 
et al., 2006). To defi  nitively demonstrate that the HC is directly 
ubiquitinated, precipitates of the 1K or 1S L
d proteins were 
boiled in 0.5% SDS and 10 mM DTT and reprecipitated with 
antibody to denatured L
d. As shown in Fig. 7 A, polyubiquitina-
tion of 1K or 1S tails was unaffected by denaturation, whereas 
β2m assembly was eliminated. This result demonstrated that 
  either hydroxylated or amide amino acid side chains can be di-
rectly Ub conjugated by mK3. If this conclusion is true, the 
linkage between the hydroxyl side chain of S and the C-terminal 
glycine residue of Ub would be an ester bond. To test the exis-
tence of this linkage, we compared the stability of the bonds 
  between Ub and 1K or 1S HCs after exposure to mild alkaline 
hydrolysis. It is known that ester bonds are more labile under 
these conditions than amide bonds, such as those formed be-
tween K residues and Ub (Hershko et al., 1980; Greene, 1981). 
Indeed, the ubiquitinated forms of the 1S mutant were undetect-
able upon incubation with either 1 M hydroxylamine, pH 9.0, or 
0.1 M NaOH (Fig. 7 B, top and bottom, respectively). Similarly, 
ubiquitinated forms of the 1T(337) mutant were also labile to 
Figure 6.  Ubiquitination of L
d by mK3 can occur on either S, T, or K resi-
dues on the tail of L
d. (A) Nomenclature and sequence alignment of the 
cyto  plasmic tails of L
d tail mutants are shown with original wt residues 
in bold, substituted residues in red, and added back residues in blue. 
(B) WT3 cells stably coexpressing mK3 and one of the L
d tail mutants were 
NP-40 lysed. After precipitation of L
d, precipitates were immunoblotted for 
Ub and L
d (left). In the right panel, the β-actin and mK3 blots were included 
to show that a similar amount of input lysate of each line was used for 
immuno  precipitation and a similar amount of mK3 was expressed in each 
line. (C) Cells coexpressing mK3 and one of the L
d tail mutants 1K, 1T(313), 
or 1T(337) were lysed, immunoprecipitated, and blotted as described in B. 
(D) After incubation for 24 h with 125 U/ml IFN-γ, cells used in B and C 
were pulse labeled with [
35S]Cys/Met for 15 min and chased for the indi-
cated times. L
d HCs were precipitated, resolved, and visualized as de-
scribed in Fig. 1 C. Relative band intensities from the gels are plotted as a 
percentage of the intensity at time zero for each line and are shown be-
neath the gel photos.JCB • VOLUME 177 • NUMBER 4 • 2007  620
mild alkaline treatment (unpublished data). As expected, the 1K 
mutant was stable to treatment with either reagent (Fig. 7 B). 
These data strongly support the hypothesis that mK3 is capable 
of facilitating the novel conjugation of ubiquitination to an S or 
T residue in the cytoplasmic tail of L
d via an ester linkage.
Discussion
The mechanism of how substrates are retrotranslocated or dis-
located from ER membrane is still poorly understood. It is 
known that ubiquitination plays a crucial role in this action, but 
when it happens and whether a direct Ub conjugation to the 
substrate is required are not clear. For soluble lumenal sub-
strates, mutations in the ubiquitination system result in sub-
strates accumulating in the ER (Jarosch et al., 2002b), suggesting 
that the ubiquitination of substrates is required for their dislocation. 
However, because lumenal substrates are separated from the 
ubiquitination apparatus by a membrane, the substrate ubiqui-
tination obviously does not initiate their dislocation. On the 
other hand, for integral membrane proteins, one would think 
that its cytosolic portion might be the most convenient site for 
Ub conjugation, which could subsequently recruit Ub-binding 
protein and the ATPase complex required for complete extrac-
tion of the substrate. However, for several typical type I mem-
brane protein substrates, such as orphan subunit TCRα and 
MHC-I HC in the presence of US2 or US11, K residues in the 
substrate’s tail are dispensable for their dislocation (Shamu 
et al., 1999; Yu and Kopito, 1999; Furman et al., 2003). In the 
specifi  c case of US2-induced ERAD of HC, internal K residues 
were found to be required for dislocation (Hassink et al., 2006). 
However, for the other aforementioned ERAD substrates, the 
replacement of all internal Ks on these ERAD substrates did 
not affect their dislocation, suggesting a non-K–mediated form 
of ubiquitination.
One possible explanation is N-terminal ubiquitination, in 
which the fi  rst Ub moiety is fused linearly to the α-NH2 group 
of the substrate N terminus. This type of ubiquitination has been 
demonstrated for >12 proteins and, thus, provides an alterna-
tive mode of ubiquitination that may be particularly important 
for the regulation of proteins that have no accessible K residues 
(Ciechanover, 2005). In ERAD, however, such a process has not 
been well established, especially for soluble lumenal substrates 
or type I membrane substrates with their N termini in the ER 
  lumen. For these types of substrates, a partial dislocation of 
their N termini to the cytosolic side is presumably required before 
the addition of Ub because all of the functional ubiquitination 
components are located in the cytosol. Recently, Hassink et al. 
(2006) attached Ub to the N terminus of wt and K-less HCs and 
found that it did not accelerate their dislocation in the presence 
of US11. This fi  nding suggests that N-terminal ubiquitination 
does not play a role in US11-initiated extraction of HCs from 
the ER membrane.
An alternative explanation for the dislocation of K-less 
membrane proteins is that an adaptor protein is ubiquitinated 
instead of direct ubiquitination of the substrate. Ubiquitina-
tion on an adaptor could link the associated substrate with the 
extraction machinery, resulting in complete extraction of the 
substrate. Interestingly, this mechanism is supported by recent 
studies of the dislocation of K-less HC by US11 (Hassink et al., 
2006). However, the ultimate confi  rmation for such a model will 
have to await identifi  cation of the ubiquitinated adaptor protein. 
An important consideration regarding conclusions using K-less 
substrates is whether ubiquitination can occur via non-K residues. 
For example, it has been reported that MIR1 ligase (also called 
kK3) of KSHV can ubiquitinate C residues in the HC tail via 
thioester bonds, thus targeting it for degradation through an 
endocytic–lysosome pathway (Cadwell and Coscoy, 2005).
Figure 7.  Evidence for the direct conjugation of Ub to an S residue of the 
L
d tail mediated by mK3. (A) L
d HCs were precipitated by anti-L
d mAbs 
30-5-7 and 64-3-7 from NP-40 lysates of the cells expressing L
d tail 1K or 
L
d tail 1S mutant (±mK3). After incubation in 0.5% SDS and 10 mM DTT 
at room temperature for 10 min and boiling for 10 min, part of the elutes 
were reprecipitated by the conformation-independent anti-L
d mAb 64-3-7. 
Note that for this experiment, similar amounts of L
d were loaded for each 
sample. The ﬁ  rst and second precipitates were immunoblotted for Ub, L
d, 
and β2m. Ub-conjugated L
d forms (Ubn-L
d) and unconjugated L
d HCs are 
indicated. Nonspeciﬁ  c staining of antibody heavy chain (Ig HC) is also 
indicated. (B) After incubation with 30 μM MG132 for 3 h, the cells stably 
expressing L
d tail KCST-less, L
d tail 1K, or L
d tail 1S (+mK3) were lysed with 
NP-40. After precipitation of L
d, the precipitates were incubated with or 
without (−/+) 1 M sodium hydroxylamine, pH 9, for 4 h at 37°C (top) or 
with or without (−/+) 0.1 M NaOH for 2 h at 37°C (bottom). Then, the 
precipitates were subjected to SDS-PAGE and immunoblotting for Ub and 
L
d. Ub-conjugated L
d forms (Ub2-L
d or Ub3-L
d) and unconjugated L
d HCs are 
indicated. Because NaOH-treated samples were reduced by 2.5% 2ME 
before loading for SDS-PAGE, unconjugated and conjugated L
d HCs 
  migrate slower than nonreduced sodium hydroxylamine–treated samples, 
and a disassociated Ig HC band can be seen in the blot.MK3 UBIQUITINATES NONLYSINE RESIDUES ON MHC-I TAIL • WANG ET AL. 621
In the case of mK3-induced HC ubiquitination and degra-
dation, we previously showed that the substitution of all Ks in 
the tail of MHC-I HC did not affect the ubiquitination status or 
the degradation of these molecules (Wang et al., 2005). Never-
theless, deletion of the tail abolished the ubiquitination of HC, 
leading to its stabilization in the ER (Wang et al., 2005). Indeed, 
a similar phenotype has also been found in the US11-induced 
turnover of MHC-I HC (Story et al., 1999; Barel et al., 2003). 
Our erroneous explanation for these observations was that the 
tail of HC is required for the initiation of dislocation but not for 
direct tail ubiquitination.
In the present study, a complete K-less L
d and a K-less 
Ub/K-less L
d fusion protein were found to be polyubiquitinated 
and rapidly degraded in the presence of mK3. This fi  nding 
suggested that neither lumenal Ks nor an α-NH2 group of the 
N terminus of HC are essential Ub conjugation sites required by 
mK3. More importantly, we demonstrated that polyubiqui-
tinated HCs become undetectable when the tail was removed by 
proteinase K digestion or via an engineered TMB cleavage site. 
These fi  ndings demonstrated that the HC tail is the site of ubiq-
uitination. Of note, these observations were also made with wt 
L
d molecules, demonstrating that it is a normal process used by 
native protein and not merely a forced pathway used by sub-
strates having no available Ks. Furthermore, we found that 
  mutations of all K and C residues of the L
d tail did not affect 
mK3-induced ERAD. However, the additional removal of 
S and T residues in the tail abolished mK3-induced polyubiqui-
tination and stabilized the HC. These fi  ndings suggested that 
one or both of the hydroxylated amino acids were suffi  cient 
for ubiquitination.
To extend these observations using a better defi  ned ap-
proach, individual K, C, S, and T residues were reintroduced 
into L
d with a KCST-less tail. Remarkably, HCs with tails hav-
ing only one S, T(337), or K were polyubiquitinated and were 
susceptible to ERAD in the presence of mK3. However, loca-
tion was found to be important in that all effi  cacious ubiquitina-
tion sites were clustered toward the C terminus of the HC tail. 
In contrast, a tail with a membrane-proximal T residue dis-
played no detectable ubiquitination. S and T residues are poten-
tial phosphorylation sites that could be required to recruit a 
putative HC-associated protein that is ubiquitinated. To demon-
strate that HC is itself ubiquitinated, HCs with single S or K in 
their tails were denatured and reprecipitated with a class I–
 specifi  c mAb. In both cases, ubiquitinated HCs were still detec-
ted after treatment, demonstrating that Ub moieties can be 
cova  lently attached to either S, T, or K residues in the HC tail in 
the presence of mK3. In strong support of this conclusion, 2-ME 
that specifi  cally disrupts thioester bonds formed with C resi-
dues had no effect on the Ub conjugation to S or K residues of 
the HC tail in the presence of mK3. Alternatively, mild alkaline 
hydrolysis with sodium hydroxylamine or NaOH, reagents that 
are effective in cleaving ester bonds and not amide bonds, re-
moved detectable mK3-mediated ubiquitination via S or T but 
not K residues. Thus, in the presence of mK3, ester bonds are 
formed that covalently link Ub to S or T residues in the tail of 
the HC substrate, thereby defi  ning a novel form of ubiquitination. 
It will be interesting to determine whether the ability to use S and T 
as well as K residues refl  ects a unique, direct interaction of mK3 
with the HC substrate or, alternatively, may involve distinct 
cellular components such as E2 conjugation enzymes or other 
necessary cofactors.
The ubiquitination pattern induced by mK3 is somewhat 
surprising. Even when the HC substrate has a wt tail, the Ub2 
and Ub3 forms are predominant. It is noteworthy that Boname 
and Stevenson (2001) also detected HCs with predominantly 
Ub2 and Ub3 forms and few, if any, higher than Ub3 in the pres-
ence of mK3. Because the proteasome requires Ub4 to provide 
suffi  cient avidity for binding substrates for degradation (Thrower 
et al., 2000), we have considered the notion that multimers 
higher than Ub3 may be unstable and, thus, diffi  cult to detect in 
steady-state assays. Indeed, when proteasome inhibitor was 
used, Ub4 and Ub5 multimers can be detected (Figs. 2 B and 
5 D). However, proteasome inhibitors result in only modest in-
creases in forms higher than Ub3, which is likely the result of 
the fact that the 2–3-h treatment does not appreciably affect 
steady-state levels of ubiquitination. Interestingly, tails contain-
ing a single S, T, or K residue displayed an even greater pre-
dominance of Ub2 forms, although Ub3 and higher multimers 
show up on longer exposure. In any case, HC tails with only one 
S, T, or K residue are viable ERAD substrates in the presence of 
mK3, implying they are polyubiquitinated to Ub4. It is also in-
teresting that in the presence of mK3, the minimum ubiqui-
tination forms of HCs are Ub2, regardless of whether it is a wt 
or tail 1S, 1T, or 1K substrate. This may imply that mK3 facili-
tates the transfer of a premade Ub2 or Ub3 chain from cognate 
E2 to the substrates.
The fi  ndings reported in this study clarify the molecular 
basis of mK3 substrate specifi  city. Our previous study failed to 
detect an HC-specifi  c tail sequence required for mK3 inter-
action (Wang et al., 2004). The fi  nding of alternative sites for 
mK3-mediated ubiquitination reported here is consistent with 
this conclusion. Interestingly, the primary binding partner for 
mK3 is TAP, the transporter responsible for dislocating protea-
some-processed peptides into the ER lumen, and a mutagenesis 
study showed that it is the C terminus of mK3 that binds TAP 
(Wang et al., 2004). Most class I HC alleles require a physical 
association with TAP after assembly with β2m and before the 
binding of high affi  nity peptide ligands (Grandea et al., 2000). 
These combined fi  ndings suggest a proximity model whereby 
the specifi  c recognition of HC by mK3 is achieved by TAP 
binding to the mK3 C terminus, which then orients the N-terminal 
mK3 RING domain such that it can only interact with the HC 
tail. Thus, TAP is the key mK3 adaptor protein juxtaposing the 
mK3 RING domain with the HC tail to confer substrate speci-
fi  city. The demonstration here of the importance of the location 
of ubiquitination sites within the tail lends strong support to this 
proximity model. This model provides a viable general strategy 
for allowing E3s to maintain their requisite substrate specifi  city 
while facilitating the ubiquitination of a highly polymorphic 
substrate such as HC. With the required juxtaposition of mK3 
RING and HC tail, the necessary cellular ubiquitination compo-
nents, including an appropriate E2, can then be recruited, result-
ing in ubiquitination of the HC tail. This core ER membrane 
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it appears to have a redundant function (Wang et al., 2006; and 
unpublished data). ATPase p97 is also recruited to this mK3 core 
membrane complex, and this association clearly has an impact 
on mK3-induced ERAD (Wang et al., 2006).
The aforementioned fi  ndings suggest that the viral mK3 
ligase assimilates a core membrane complex in mouse cells 
similar to ERAD complexes described in yeast. In this context, 
it is interesting to compare properties and outstanding questions 
regarding the mK3 membrane complex with the aforementioned 
yeast Doa10p (ERAD-C) and Hrd1p (ERAD-L) complexes 
(Vashist and Ng, 2004; Carvalho et al., 2006; Denic et al., 2006). 
HC tail ubiquitination by mK3 suggests that it mimics an 
ERAD-C pathway induced by substrates with a cytosolic lesion 
(Vashist and Ng, 2004; Carvalho et al., 2006), and ERAD-C 
does not require Der1p, as mK3 does not require the Der1p ho-
mologue Derlin1 (Wang et al., 2006; and unpublished data). 
Models such as ERAD-C and the mK3 model would not require 
the partial dislocation of substrate before ubiquitination, and 
polyubiquitination of the tail could be the initiating signal for 
dislocation. It is intriguing to speculate that mK3 may also be a 
component of the dislocation channel, if indeed one is required 
for this pathway. In the context of an ERAD-L–like model, it is 
unclear whether molecular interactions are required in the ER 
lumen to promote substrate dislocation. Although mK3 has only 
12 amino acids in the ER lumen, it could disrupt transmem-
brane interactions between proteins within the core membrane 
complex, and this disruption could induce ER protein folding 
sensors (chaperones) to bind the ectodomain of HC and facili-
tate dislocation. Defi  ning the molecular composition of the dis-
location pore and the signals that initiate substrate dislocation 
are key questions for any of these Ub ligase–induced membrane 
complexes involved in distinct ERAD pathways. In any case, 
fi  ndings with viral ligase mK3 suggest that it can assemble a 
unique core ER membrane complex that specifi  cally detects 
MHC class I HCs and targets them for ERAD.
In summary, we report that the mK3 ligase directly ubiq-
uitinates its HC substrate at tail S, T, or K residues. This obser-
vation obviates the need for the partial dislocation of HC before 
ubiquitination, suggesting a vectorial exit from the ER. It will 
be interesting to determine whether other ERAD pathways in-
volving transmembrane protein substrates might also involve tail 
ubiquitination using non-K residues. Furthermore, the fact that 
mK3 has numerous viral (including MIR1) and cellular homo-
logues makes it attractive to speculate that other ubiquitination-
regulated processes use similar nonconventional methods of 
Ub conjugation.
Materials and methods
Cell lines and ﬂ  ow cytometry
Mouse B6/WT3 (WT3, H-2
b) cells were described previously (Wang et al., 
2004). 293T cells (DuBridge et al., 1987) were used for the production of eco-
tropic retrovirus. All cells were maintained in complete RPMI 1640 with 10% 
FCS (HyClone) as described previously (Lybarger et al., 2003). Retrovirus-
containing supernatants were produced using the Vpack vector system 
(Stratagene) with transient transfection of 293T cells. Cells transduced by 
the pMIN-containing virus were enriched by geneticine selection, whereas 
GFP
+ cells from pMIG-transduced lines were enriched by cell sorting. 
Where indicated, cells were cultured for 24 h with 125 U/ml of mouse 
IFN-γ (Biosource International) and for 2–3 h with 30–60 μM of the protea-
some inhibitor MG132 (Boston Biochem) or 5 μM clasto-lactacystin β-lactone 
(Calbiochem) before harvesting with trypsin-EDTA. All ﬂ  ow  cytometric 
analyses were performed as previously described (Lybarger et al., 2003).
DNA constructs
Two retroviral expression vectors, pMSCV.IRES.GFP (pMIG) and pMSCV.
IRES.neo (pMIN; Wang et al., 2004), were used to express mK3 and L
d 
constructs, respectively. mK3 sequence was obtained by PCR ampliﬁ  cation 
of the K3 gene from a γHV68 subclone (Virgin et al., 1997). Both mK3 
and L
d mutants were generated by site-directed mutagenesis (Stratagene). 
Ub/L
d fusion constructs were made by overlapping PCR, wherein the un-
cleavable wt and K-less Ub sequences (wt Ub and K-less Ub, with replace-
ment of glycine 76 to valine) were PCR ampliﬁ   ed from the constructs 
pLZRS-Ub G76V-HLA.A2 and pLZRS-UbK®R G76V-HLA.A2 (Hassink et al., 
2006). The correct sequences for all of the constructs were conﬁ  rmed by 
DNA sequencing.
Antibodies
Rabbit anti-mK3, Ub antibodies, β-actin (AC-74) antibodies, and mAbs 
30-5-7 and 64-3-7 to folded and open forms of MHC class I L
d were previ-
ously described (Lybarger et al., 2003). Antibodies (Ra20873) to the cyto-
plasmic tail of L
d were produced in rabbits immunized with the cytoplasmic 
tail peptide (Smith et al., 1995).
Immunoprecipitation and immunoblots
Immunoprecipitation and immunoblotting were conducted as previously 
described (Lybarger et al., 2003). In brief, cells were lysed in PBS buffer 
containing 1% NP-40, 20 mM iodoacetamide (Sigma-Aldrich), and Com-
plete mini protease inhibitors (Roche) or 0.4 mM PMSF (Sigma-Aldrich). 
Postnuclear lysates were incubated with protein A–Sepharose beads 
(Sigma-Aldrich) and antibodies. After washing beads four times with PBS/
iodoacetamide buffer containing 0.15% NP-40, immunoprecipitates were 
eluted from protein A by boiling for 3 min in lithium dodecyl sulfate sample 
buffer (Invitrogen). For endo H treatment, immunoprecipitates were eluted 
in 10 mM Tris-HCl, pH 6.8, with 0.5% SDS, and the elutes then were mixed 
with an equal volume of 100 mM sodium acetate, pH 5.4, and incubated 
with 1 μU endo H (MP Biomedicals) at 37°C for 2 h. Immunoblotting was 
performed after SDS-PAGE separation of precipitated proteins or cell lysates 
as previously described (Yu et al., 2002). Speciﬁ  c proteins were visualized 
by chemiluminescence using the ECL system (GE Healthcare).
Metabolic labeling and pulse chase
After 30 min of preincubation in Cys- and Met-free medium (MEM-Earle’s 
with 5% dialyzed FCS), cells were pulse labeled with Express [
35S]Cys/
Met labeling mix (Perkin Elmer) at 150 μCi/ml for 10–15 min. Chase was 
initiated by the addition of an excess of unlabeled Cys/Met (5 mM each). 
Immunoprecipitation was performed as described in the previous section. 
Samples were subjected to SDS-PAGE, and gels were treated with Amplify 
(GE Healthcare), dried, and exposed to BioMax-MR ﬁ  lm (Kodak).
ER isolation and proteinase K digestion
Cells were incubated in cold hypotonic extraction buffer containing 10 mM 
Hepes, pH 7.8, 25 mM KCl, and 1 mM EGTA for 20 min and were re-
suspended in isotonic extraction buffer containing 10 mM Hepes, pH 7.8, 
250 mM sucrose, 25 mM KCl, and 1 mM EGTA before they were broken 
with 20 strokes of Dounce homogenizer on ice. The homogenate was 
then subjected to serial centrifugations at 1,000 g for 10 min, 10,000 g for 
10 min, and 100,000 g for 60 min, which were all performed at 4°C. The 
100,000 g pellet was resuspended in PBS with 20 mM iodoacetamide. 
Two aliquots of the suspension were incubated on ice with or without 
10 μg/ml proteinase K (Invitrogen) for 20 min. After the digestion was 
stopped by 2 mM PMSF, NP-40 was added to a ﬁ  nal concentration of 1% to 
disrupt the membranes. PMSF and NP-40 were also added into 100,000 g 
supernatant fractions. Subsequent immunoprecipitation and immuno-
blotting were performed as described above in the Immunoprecipitation 
and immunoblots section.
Sodium hydroxylamine and sodium hydroxide treatment
Immunoprecipitates were boiled in 0.5% SDS for 3 min followed by incu-
bation in either 1 M sodium hydroxylamine, pH 9, for 4 h at 37°C or sodium 
hydroxide (0.1 M NaOH) for 2 h at 37°C. Mock-treated samples were in-
cubated with PBS. Before SDS-PAGE analysis, the sodium hydroxylamine–
treated samples were dialyzed against PBS overnight at 4°C using 3500 
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